Meroterpenoids with a large conjugated system from Ganoderma lucidum and their inhibitory activities against renal fibrosis

Fitoterapia. 2022 Sep:161:105257. doi: 10.1016/j.fitote.2022.105257. Epub 2022 Jul 29.

Abstract

Baoslingzhines A-E (1-5), five new meroterpenoids were isolated from the fruiting bodies of Ganoderma lucidum. The structures including their absolute configurations were characterized by using spectroscopic and computational methods. Compound 1 is a novel trinormeroterpenoid featuring the presence of an unusual dihydronaphthalene representing an unprecedented meroterpenoid skeleton. Compounds 2-4 are mononormeroterpenoids characteristic of a large conjugated system. Among them, racemic 3 and 4 were separated by HPLC on chiral phase. Biological evaluation toward kidney fibrosis found that compounds 2 and (+)-3 could inhibit the expression of fibronectin and collagen I dose dependently in TGF-β1-induced rat kidney proximal tubular cells (NRK-52e). Additionally, (+)-3 could also down regulate ɑ-SMA in a concentration dependent manner. Further investigation showed that 2 could inhibit Smad2 phosphorylation.

Keywords: Ganoderma lucidum; Large conjugated system; Meroterpenoids; Renal fibrosis.

MeSH terms

  • Animals
  • Fibrosis
  • Ganoderma* / chemistry
  • Molecular Structure
  • Rats
  • Reishi*
  • Terpenes / chemistry
  • Terpenes / pharmacology
  • Transforming Growth Factor beta1 / pharmacology

Substances

  • Terpenes
  • Transforming Growth Factor beta1